BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31099614)

  • 1. Evolving Treatments for Primary Central Nervous System Lymphoma.
    Ferreri AJM; Holdhoff M; Nayak L; Rubenstein JL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():454-466. PubMed ID: 31099614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible role of maintenance treatment for primary central nervous system lymphoma.
    Bairey O; Siegal T
    Blood Rev; 2018 Sep; 32(5):378-386. PubMed ID: 29551465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of primary central nervous system lymphoma.
    Han CH; Batchelor TT
    Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
    Schorb E; Finke J; Ihorst G; Kasenda B; Fricker H; Illerhaus G
    BMC Cancer; 2019 Mar; 19(1):287. PubMed ID: 30925912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and opportunities in primary CNS lymphoma: A systematic review.
    Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
    Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma: essential points in diagnosis and management.
    Paydas S
    Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary CNS Lymphoma.
    Grommes C; DeAngelis LM
    J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary central nervous system lymphoma.
    Ekenel M; DeAngelis LM
    Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in treatment of elderly primary central nervous system lymphoma.
    Martinez-Calle N; Isbell LK; Cwynarski K; Schorb E
    Br J Haematol; 2022 Feb; 196(3):473-487. PubMed ID: 34448202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches in primary central nervous system lymphoma.
    Fraser E; Gruenberg K; Rubenstein JL
    Chin Clin Oncol; 2015 Mar; 4(1):11. PubMed ID: 25841718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
    Langner-Lemercier S; Houillier C; Soussain C; Ghesquières H; Chinot O; Taillandier L; Soubeyran P; Lamy T; Morschhauser F; Benouaich-Amiel A; Ahle G; Moles-Moreau MP; Moluçon-Chabrot C; Bourquard P; Damaj G; Jardin F; Larrieu D; Gyan E; Gressin R; Jaccard A; Choquet S; Brion A; Casasnovas O; Colin P; Reman O; Tempescul A; Marolleau JP; Fabbro M; Naudet F; Hoang-Xuan K; Houot R
    Neuro Oncol; 2016 Sep; 18(9):1297-303. PubMed ID: 26951382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system lymphoma: overview of current treatment strategies.
    Brastianos PK; Batchelor TT
    Hematol Oncol Clin North Am; 2012 Aug; 26(4):897-916. PubMed ID: 22794289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the management of primary central nervous system lymphoma.
    Sun X; Lv L; Wu Y; Cui Q; Sun S; Ji N; Liu Y
    Crit Rev Oncol Hematol; 2023 Aug; 188():104042. PubMed ID: 37277008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary central nervous system lymphomas].
    Hrudková M; Belada D; Smolej L; Zák P; Malý J
    Vnitr Lek; 2010 Aug; 56(8):795-800. PubMed ID: 20845611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphoma: Novel precision therapies.
    Mondello P; Mian M; Bertoni F
    Crit Rev Oncol Hematol; 2019 Sep; 141():139-145. PubMed ID: 31295667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary CNS lymphoma.
    Maher EA; Fine HA
    Semin Oncol; 1999 Jun; 26(3):346-56. PubMed ID: 10375091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
    Soussain C; Suzan F; Hoang-Xuan K; Cassoux N; Levy V; Azar N; Belanger C; Achour E; Ribrag V; Gerber S; Delattre JY; Leblond V
    J Clin Oncol; 2001 Feb; 19(3):742-9. PubMed ID: 11157026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consolidation Therapy in Primary Central Nervous System Lymphoma.
    Kim P; Omuro A
    Curr Treat Options Oncol; 2020 Jul; 21(9):74. PubMed ID: 32725379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances.
    Chihara D; Dunleavy K
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):73-79. PubMed ID: 33288483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.